GE HealthCare Technologies (NASDAQ:GEHC) Price Target Raised to $79.00 at BTIG Research

GE HealthCare Technologies (NASDAQ:GEHC) had its target price boosted by investment analysts at BTIG Research from $75.00 to $79.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s price objective points to a potential upside of 11.59% from the company’s previous close.

GEHC has been the subject of a number of other reports. BNP Paribas Exane decreased their price target on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Argus cut their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Oppenheimer reiterated an “outperform” rating and issued a $85.00 target price on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Jefferies Financial Group cut their price target on GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Finally, HSBC reduced their price objective on shares of GE HealthCare Technologies from $100.00 to $90.00 in a research report on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average price target of $76.59.

GE HealthCare Technologies Trading Up 10.4%

Shares of NASDAQ GEHC traded up $6.69 during midday trading on Wednesday, reaching $70.80. The stock had a trading volume of 10,087,008 shares, compared to its average volume of 4,546,572. The company’s 50 day moving average price is $63.68 and its 200 day moving average price is $70.80. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies has a twelve month low of $58.75 and a twelve month high of $89.77. The firm has a market cap of $32.20 billion, a price-to-earnings ratio of 16.98, a price-to-earnings-growth ratio of 1.66 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same period in the prior year, the company posted $1.06 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.8% compared to the same quarter last year. As a group, sell-side analysts expect that GE HealthCare Technologies will post 4.89 EPS for the current year.

Insider Activity

In other GE HealthCare Technologies news, CEO Peter J. Arduini acquired 4,169 shares of the company’s stock in a transaction on Thursday, April 30th. The shares were purchased at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the purchase, the chief executive officer owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Frank R. Jimenez bought 1,750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The shares were acquired at an average cost of $60.45 per share, with a total value of $105,787.50. Following the completion of the transaction, the insider owned 93,932 shares of the company’s stock, valued at $5,678,189.40. This represents a 1.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have acquired 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by insiders.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds have recently bought and sold shares of GEHC. Western Wealth Management LLC lifted its position in shares of GE HealthCare Technologies by 2.4% during the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after purchasing an additional 125 shares in the last quarter. United Community Bank grew its holdings in shares of GE HealthCare Technologies by 10.2% in the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock valued at $116,000 after acquiring an additional 130 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of GE HealthCare Technologies by 3.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock valued at $293,000 after acquiring an additional 134 shares during the last quarter. Quadrant Capital Group LLC boosted its position in GE HealthCare Technologies by 1.1% in the fourth quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock worth $1,030,000 after purchasing an additional 140 shares during the last quarter. Finally, Mount Vernon Associates Inc. MD grew its stake in GE HealthCare Technologies by 0.8% in the 1st quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after purchasing an additional 144 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GEHC beat earnings and revenue estimates. Adjusted earnings were $1.13 per share, above the $1.04 consensus and up from $1.06 a year earlier. Revenue rose approximately 5.7% to $5.29 billion, slightly exceeding the $5.26 billion estimate. GE HealthCare Technologies Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Orders and backlog reached records. Orders increased 11.1%, with growth reported across every segment, while backlog climbed to $23.9 billion. The results suggest solid demand and improved visibility for future revenue. GEHC Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Imaging demand supported profitability. Strong demand for diagnostic and imaging devices helped drive the quarterly performance. Refunds related to U.S. tariffs also benefited results. GE HealthCare Beats Quarterly Profit Estimates
• Positive Sentiment: Options activity reflected bullish positioning. Traders purchased 8,956 call options, about 45% above average call volume, indicating increased speculative interest following the earnings report.
• Neutral Sentiment: Management said Patient Care Solutions remains a focus as it works to restore growth and profitability, and the company is reviewing strategies for that business. This creates a continuing execution risk despite the strong consolidated results. GE HealthCare Reports Second Quarter 2026 Financial Results

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.